-+ 0.00%
-+ 0.00%
-+ 0.00%
Tianyu Co., Ltd. announced on July 23 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a “Drug Registration Certificate” for brapiprazole tablets approved and issued by the State Drug Administration. This product is used to treat schizophrenia in adults.
Share
Listen to the news
Tianyu Co., Ltd. announced on July 23 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a “Drug Registration Certificate” for brapiprazole tablets approved and issued by the State Drug Administration. This product is used to treat schizophrenia in adults.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending